Circulating Endothelial Cells as a Marker of Endothelial Injury in Severe COVID -19
- PMID: 32812049
- PMCID: PMC7454721
- DOI: 10.1093/infdis/jiaa528
Circulating Endothelial Cells as a Marker of Endothelial Injury in Severe COVID -19
Abstract
Beside the commonly described pulmonary expression of the coronavirus disease 2019 (COVID-19), major vascular events have been reported. The objective of this study was to investigate whether increased levels of circulating endothelial cells (CECs) might be associated with severe forms of COVID-19. Ninety-nine patients with COVID-19 were enrolled in this retrospective study. Patients in the intensive care units (ICU) had significantly higher CEC counts than non-ICU patients and the extent of endothelial injury was correlated with putative markers of disease severity and inflammatory cytokines. Together, these data provide in vivo evidence that endothelial injury is a key feature of COVID-19.
Keywords: COVID-19; circulating endothelial cells; endothelial injury.
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
